Life Sciences & Technology Venture Finance

Industry focus and expertise is our advantage.

Flexible growth debt capital for businesses advancing innovative technologies and life science products.

$ 0 B
Sourced Commitments*
0 +
# of Transactions*
$5– 0 M+
Deal Sizes

Our Life Sciences & Technology Venture Finance team collaborates with companies to structure and deliver scaled, flexible, and capital-efficient financing solutions.

Our minimally dilutive capital serves as an adjunct to equity for financing acquisitions, enhancing a product launch, or advancing development-stage programs. We specialize in senior secured term loans ranging from $5 million to $200 million+ and can combine these with asset based lines of credit for commercial-stage companies to optimize cost of capital.

We have extensive experience working with emerging, commercial stage medical device, healthcare information technology, research tools, and diagnostics companies, and development-stage biotech and pharma companies. In technology, our venture debt experts work with private and public commercial stage companies in the enterprise software, networking, and hardware industries.

Funding across industry segments

Biotechnology
Biotechnology
Pharmaceuticals
Pharmaceuticals
Tools & Diagnostics
Tools & Diagnostics
Contract Drug Manufacturing Organization
Contract Drug Manufacturing Organization
Healthcare Technology
Healthcare Technology
Technology
Technology
Medical Devices
Medical Devices

*Based on sourcing deal count/volume between September 16, 2008 – September 30, 2022.

Delivering capital solutions that work

Life Sciences & Technology Venture Finance
$20,000,000
Senior Credit & Revolving Facility
Life Sciences & Technology Venture Finance
Q'Apel Medical. Inc.
Medical Devices
Transaction role
Sole Lender
Use of proceeds
Other
Life Sciences & Technology Venture Finance
$40,000,000
Senior Credit & Revolving Facility
Life Sciences & Technology Venture Finance
Telesis Bio
Tools & Diagnostics
Transaction role
Lead Arranger & Admin Agent
Use of proceeds
Refinance
Life Sciences & Technology Venture Finance
$30,000,000
Senior Credit & Revolving Facility
Life Sciences & Technology Venture Finance
Keystone Dental Group
Medical Devices
Transaction role
Sole Lender
Use of proceeds
Refinance
Life Sciences & Technology Venture Finance
$50,000,000
Senior Credit & Revolving Facility
Life Sciences & Technology Venture Finance
TELA Bio. Inc.
Medical Devices
Transaction role
Lead Arranger & Admin Agent
Use of proceeds
Refinance
“We are grateful for MidCap Financial’s financing support. Their collaborative and creative approach was instrumental as we negotiated our successful acquisition by Teladoc.”
Joe DeVivo
CEO
InTouch Health (Acquired by Teladoc 2020)
“THP partners with MidCap Financial because of their collaborative approach, long term orientation, and understanding of what it takes to build a growth business. Their debt solutions are competitive, creative, and can scale meaningfully, and their team is responsive and flexible.”
Alex Herzick
Telegraph Hill Partners
“MidCap Financial has been an invaluable long-term debt capital provider for our company. As our business has grown, MidCap has been uniquely creative and has customized our financing terms and structure to fit our evolving needs. As a result, MidCap Financial has readily scaled with us as we have grown from private company without institutional equity capital to a publicly-traded company.”
Jesse Selnick
CFO
Sight Sciences

Meet Your Life Sciences & Technology Venture Finance Team

Interested?

Reach out to learn more about how Life Sciences & Technology Venture Finance can serve your specific needs.

Interested in Midcap Financial Solutions

Get in touch

CONTACT US

Have a question?

CAREERS

Our team is growing. So can you.
The conversation starts here.